ProfileGDS5678 / 1445498_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 10% 9% 10% 10% 10% 11% 10% 10% 11% 11% 10% 10% 11% 10% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.2808910
GSM967853U87-EV human glioblastoma xenograft - Control 22.233019
GSM967854U87-EV human glioblastoma xenograft - Control 32.2612110
GSM967855U87-EV human glioblastoma xenograft - Control 42.2005710
GSM967856U87-EV human glioblastoma xenograft - Control 52.1992810
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.3194211
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.2655710
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.2419610
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2401611
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.2509511
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.2422310
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.225210
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.2684711
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.2510310